Ashika Investment Managers launches Ashika Mid & Small Cap Fund, an open-ended Category III AIF
MUMBAI, India, Dec. 9, 2025 /PRNewswire/ -- Ashika Investment Managers Pvt. Ltd.…
Boost Battle: Building Trading Momentum For A Chance at 10,000 USDT in Prizes Weekly
DUBAI, UAE, Dec. 9, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
Linglong Tire Holds 50th Anniversary Global Partners Conference, Unveiling Green-Tech Innovations and Future Strategy
YANTAI, China, Dec. 9, 2025 /PRNewswire/ -- On December 7, Linglong Tire convened…
SANY and Pony.ai Announce Mass-Production Readiness of Fourth-Generation Autonomous Heavy-Duty Truck
BEIJING, Dec. 8, 2025 /PRNewswire/ -- SANY Group announced that the fourth-generation…
Bisleri strengthens its UAE presence with a strategic three-year Hydration Partnership with the Emirates Cricket Board
Bisleri International, India’s leading packaged drinking water brand, has entered a landmark…
Kia Launches Inspiration Connects Us All Campaign Ahead of FIFA World Cup 2026
New campaign highlights Kia’s commitment to promoting unity and connection for people…
Kia PV5 Cargo Achieves Maximum FiveStar Rating in 2025 Euro NCAP Commercial Van Safety Assessment
Kia PV5 Cargo earns the top five-star rating in the 2025 Euro…
Latest Data of InnoCares Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
December 08, 2025 21:04 ET | Source: InnoCare Pharma BEIJING, Dec. 08,…
ASH 2025 | Updated Data for Ascentage Pharmas Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI…
DBS Named Global Bank of the Year 2025 by The Banker
Acknowledged for exceptional performance and innovative use of technology, including AI and…